Cited by 92Pulmonary Hypertension Research and TreatmentsCancer, Hypoxia, and MetabolismNitric Oxide and Endothelin Effects

The Hypoxia-Inducible Factor-2α Is Stabilized by Oxidative Stress Involving NOX4

Diebold, Isabel, Flügel, Daniela, Becht, Sabine, BelAiba, Rachida S., Bonello, Steve, Hess, John, Kietzmann, Thomas, Görlach, Agnes·2010·Antioxidants & Redox Signaling

Abstract

The hypoxia-inducible factor-2alpha (HIF-2alpha) contributes to the vascular response to hypoxia. Hypoxia inhibits prolyl hydroxylation of the N-terminal transactivation domain (N-TAD), thus preventing binding of the von Hippel-Lindau protein (pVHL) and proteasomal degradation; additionally, hypoxia inhibits asparagyl hydroxylation of the C-TAD, thus diminishing cofactor recruitment. Reactive oxygen species (ROS) derived from NADPH oxidases (NOXs) have been shown to control vascular functions and to promote vascular remodeling. However, whether HIF-2alpha, ROS, and NOXs are linked under such nonhypoxic conditions is unclear. We found that activation of NOX4 by thrombin or H(2)O(2) increased HIF-2alpha protein because of decreased pVHL binding in pulmonary artery smooth muscle cells (PASMCs). Thrombin, H(2)O(2), and NOX4 overexpression increased HIF-2alpha N-TAD and C-TAD activity, which was prevented by ascorbate treatment or mutation of the hydroxylation sites in the TADs. HIF-2alpha also mediated induction of plasminogen activator inhibitor-1 and the proliferative response to thrombin, H(2)O(2), or NOX4 overexpression. Thus, ROS derived from NOX4 in response to thrombin stabilize HIF-2alpha by preventing hydroxylation of the N- and C-TAD, thus allowing formation of transcriptionally active HIF-2alpha, which promotes PASMC proliferation. Together, these findings present the first evidence that HIF-2alpha is critically involved in the ROS-regulated vascular remodeling process…

Integrity signals

Registry

Crossref · 10.1089/ars.2009.3014

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ROS-dependent modulation of PHD2 activity under mild hypoxia alters hydroxylase function without complete oxygen withdrawal.

    “This framework was further refined by studies identifying ROS-dependent modulation of PHD2 activity under mild hypoxia, in which oxidative modification alters hydroxylase function without complete oxygen withdrawal [207,208].”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [207]

  • HIF stabilization frequently reflects redox-controlled tuning of oxygen-sensing enzymes within a permissive oxygen range, rather than absolute hypoxia.

    “Together, these data provide a mechanistic explanation for pseudohypoxia and support the view that HIF stabilization frequently reflects redox-controlled tuning of oxygen-sensing enzymes within a permissive oxygen range, rather than absolute hypoxia.”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [207]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Diebold, I., Flügel, D., Becht, S., BelAiba, R. S., Bonello, S., Hess, J., Kietzmann, T., & Görlach, A.
Affiliations
  • Deutsches Herzzentrum München (DE)
  • University of Kaiserslautern (DE)
Corresponding author
Görlach, Agnes
Venue
Antioxidants & Redox Signaling
Published
2010-08-15
Volume
13
Issue
4
Pages
425-436
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
OpenAlex
W2036748771
Cited by
92
References
7
Citations by year
2026: 5 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 10 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 9
FWCI
4.49
Type
journal article
Language
en
Open access
closed
Locations
  • Antioxidants and Redox Signaling (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
HIF-2α, NOX4, reactive oxygen species, NADPH oxidase, protein stabilization, von Hippel-Lindau protein, prolyl hydroxylation, thrombin, hydrogen peroxide, plasminogen activator inhibitor-1, pulmonary artery smooth muscle cells, vascular remodeling, smooth muscle cell proliferation, hypoxia
MeSH terms
NADPH Oxidase 4, Endothelial PAS Domain-Containing Protein 1, Animals, Ascorbic Acid, Cells, Cultured, Humans, Hydrogen Peroxide, Iron, Thrombin, Blotting, Western, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Cell Line, Tumor, Cell Proliferation, Rats, Basic Helix-Loop-Helix Proteins, Von Hippel-Lindau Tumor Suppressor Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review